FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Daniel O'Connor

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Rats
Cattle

Anatomy

Co-author Network

Publications

TOP 3
Sunder Mudaliar; A R Chang; Vanita Aroda; E Chao; P Burke; Sunita Baxi; K A Griver; Daniel O'Connor; Robert R Henry
Effects of intensive insulin therapy alone and with added pioglitazone on renal salt/water balance and fluid compartment shifts in type 2 diabetes.
Yuqing Chen; Gen Wen; Fangwen Rao; Kuixing Zhang; Lei Wang; Juan Lorenzo Rodriguez Flores; Amber P Sanchez; Manjula Mahata; LAURENT TAUPENOT; Ping Sun; Sushil K Mahata; Bamidele Tayo; Nicholas J Schork; Michael G Ziegler; Bruce A Hamilton; Daniel O'Connor
Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure.
Pei-An Betty Shih; Lei Wang; Stephane CHIRON; Gen Wen; Caroline Nievergelt; Manjula Mahata; Srikrishna Khandrika; Fangwen Rao; Maple M Fung; Sushil K Mahata; Bruce A Hamilton; Daniel O'Connor
Peptide YY (PYY) gene polymorphisms in the 3'-untranslated and proximal promoter regions regulate cellular gene expression and PYY secretion and metabolic syndrome traits in vivo.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Daniel O'Connor (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Sunder Mudaliar; A R Chang; Vanita Aroda; E Chao; P Burke; Sunita Baxi; K A Griver; Daniel O'Connor; Robert R Henry
Effects of intensive insulin therapy alone and with added pioglitazone on renal salt/water balance and fluid compartment shifts in type 2 diabetes.
Diabetes, obesity & metabolism 2010;12(2):133-8.
2010: Yuqing Chen; Gen Wen; Fangwen Rao; Kuixing Zhang; Lei Wang; Juan Lorenzo Rodriguez Flores; Amber P Sanchez; Manjula Mahata; LAURENT TAUPENOT; Ping Sun; Sushil K Mahata; Bamidele Tayo; Nicholas J Schork; Michael G Ziegler; Bruce A Hamilton; Daniel O'Connor
Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure.
Journal of hypertension 2010;28(1):76-86.
2009: Pei-An Betty Shih; Lei Wang; Stephane CHIRON; Gen Wen; Caroline Nievergelt; Manjula Mahata; Srikrishna Khandrika; Fangwen Rao; Maple M Fung; Sushil K Mahata; Bruce A Hamilton; Daniel O'Connor
Peptide YY (PYY) gene polymorphisms in the 3'-untranslated and proximal promoter regions regulate cellular gene expression and PYY secretion and metabolic syndrome traits in vivo.
The Journal of clinical endocrinology and metabolism 2009;94(11):4557-66.
2009: Ryan S Friese; Fangwen Rao; Srikrishna Khandrika; Brenda Thomas; Michael G Ziegler; Geert W Schmid-Schönbein; Daniel O'Connor
Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease.
Clinical and experimental hypertension (New York, N.Y. : 1993) 2009;31(7):521-33.
2009: Nilima Biswas; Juan Lorenzo Rodriguez Flores; Maite COUREL; Jiaur R Gayen; Sucheta M Vaingankar; Manjula Mahata; Justin W Torpey; LAURENT TAUPENOT; Daniel O'Connor; Sushil K Mahata
Cathepsin L colocalizes with chromogranin a in chromaffin vesicles to generate active peptides.
Endocrinology 2009;150(8):3547-57.
2009: Vibha Bhatnagar; Daniel O'Connor; Victoria H Brophy; Nicholas J Schork; Erin Richard; Rany M Salem; Caroline Nievergelt; George L Bakris; John P Middleton; Keith C Norris; Jackson Wright; Leena Hiremath; Gabriel Contreras; Lawrence J Appel; Michael Lipkowitz
G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.
American journal of hypertension 2009;22(3):332-8.
2008: Fangwen Rao; Lian Zhang; Jennifer Wessel; Kuixing Zhang; Gen Wen; Brian P Kennedy; Brinda K Rana; Madhusudan Das; Juan L Rodriguez-Flores; Douglas W Smith; Peter E Cadman; Rany M Salem; Sushil K Mahata; Nicholas J Schork; LAURENT TAUPENOT; Michael G Ziegler; Daniel O'Connor
Adrenergic polymorphism and the human stress response.
Annals of the New York Academy of Sciences 2008;1148():282-96.
2008: Nitish R Mahapatra; LAURENT TAUPENOT; Maite COUREL; Sushil K Mahata; Daniel O'Connor
The trans-Golgi proteins SCLIP and SCG10 interact with chromogranin A to regulate neuroendocrine secretion.
Biochemistry 2008;47(27):7167-78.
2008: Y Chen; Fangwen Rao; Juan Lorenzo Rodriguez Flores; Nitish R Mahapatra; Manjula Mahata; Gen Wen; Rany M Salem; P-A B Shih; Madhusudan Das; Nicholas J Schork; Michael G Ziegler; Bruce A Hamilton; Sushil K Mahata; Daniel O'Connor
Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure.
Kidney international 2008;74(1):115-25.
2008: M M Fung; O H Viveros; Daniel O'Connor
Diseases of the adrenal medulla.
Acta physiologica (Oxford, England) 2008;192(2):325-35.
2008: Nilima Biswas; Sucheta M Vaingankar; Manjula Mahata; Madhusudan Das; Jiaur R Gayen; LAURENT TAUPENOT; Justin W Torpey; Daniel O'Connor; Sushil K Mahata
Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin.
Endocrinology 2008;149(2):749-57.
2008: Maple M Fung; Carie Nguyen; Parag Mehtani; Rany M Salem; Brandon Perez; Brenda Thomas; Madhusudan Das; Nicholas J Schork; Sushil K Mahata; Michael G Ziegler; Daniel O'Connor
Genetic variation within adrenergic pathways determines in vivo effects of presynaptic stimulation in humans.
Circulation 2008;117(4):517-25.
2007: Vibha Bhatnagar; Daniel O'Connor; Nicholas J Schork; Rany M Salem; Caroline Nievergelt; Brinda K Rana; Douglas W Smith; George L Bakris; John P Middleton; Keith C Norris; Jackson T Wright; DeAnna E. Cheek; Leena Hiremath; Gabriel Contreras; Lawrence J Appel; Michael Lipkowitz
Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.
Journal of hypertension 2007;25(10):2082-92.
2007: Coleman A Mosley; LAURENT TAUPENOT; Nilima Biswas; Joseph P Taulane; Norman H Olson; Sucheta M Vaingankar; Gen Wen; Nicholas J Schork; Michael G Ziegler; Sushil K Mahata; Daniel O'Connor
Biogenesis of the secretory granule: chromogranin A coiled-coil structure results in unusual physical properties and suggests a mechanism for granule core condensation.
Biochemistry 2007;46(38):10999-1012.
2007: Lian Zhang; Fangwen Rao; Kuixing Zhang; Srikrishna Khandrika; Madhusudan Das; Sucheta M Vaingankar; Xuping Bao; Brinda K Rana; Douglas W Smith; Jennifer Wessel; Rany M Salem; Juan Lorenzo Rodriguez Flores; Sushil K Mahata; Nicholas J Schork; Michael G Ziegler; Daniel O'Connor
Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk.
The Journal of clinical investigation 2007;117(9):2658-71.
2007: Roisin Connolly; Damien Gates; Nellie Loh; Dilair Baban; Rajesh Thakker; Brian Johnston; David McCance; Joy Ardill; Daniel O'Connor; LAURENT TAUPENOT; Ann McGinty
Cox-2 promotes chromogranin A expression and bioactivity: evidence for a prostaglandin E2-dependent mechanism and the involvement of a proximal cyclic adenosine 5'-monophosphate-responsive element.
Endocrinology 2007;148(9):4310-7.
2007: Fangwen Rao; Lian Zhang; Jennifer Wessel; Kuixing Zhang; Gen Wen; Brian P Kennedy; Brinda K Rana; Madhusudan Das; Juan Lorenzo Rodriguez Flores; Douglas W Smith; Peter E Cadman; Rany M Salem; Sushil K Mahata; Nicholas J Schork; LAURENT TAUPENOT; Michael G Ziegler; Daniel O'Connor
Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo.
Circulation 2007;116(9):993-1006.
2007: Gen Wen; Jennifer Wessel; Weidong Zhou; Georg Benedikt Ehret; Fangwen Rao; Mats Stridsberg; Sushil K Mahata; Peter M Gent; Madhusudan Das; Richard S Cooper; Aravinda Chakravarti; Huilin Zhou; Nicholas J Schork; Daniel O'Connor; Bruce A Hamilton
An ancestral variant of Secretogranin II confers regulation by PHOX2 transcription factors and association with hypertension.
Human molecular genetics 2007;16(14):1752-64.
2007: Fangwen Rao; Gen Wen; Jiaur R Gayen; Madhusudan Das; Sucheta M Vaingankar; Brinda K Rana; Manjula Mahata; Brian P Kennedy; Rany M Salem; Mats Stridsberg; Kenneth Abel; Douglas W Smith; Eleazar Eskin; Nicholas J Schork; Bruce A Hamilton; Michael G Ziegler; Sushil K Mahata; Daniel O'Connor
Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.
Circulation 2007;115(17):2271-81.
2007: Elizabeth O Lillie; Manjula Mahata; Srikrishna Khandrika; Fangwen Rao; Richard A Bundey; Gen Wen; Yuqing Chen; LAURENT TAUPENOT; Douglas W Smith; Sushil K Mahata; Michael G Ziegler; Myles Cockburn; Nicholas J Schork; Daniel O'Connor
Heredity of endothelin secretion: human twin studies reveal the influence of polymorphism at the chromogranin A locus, a novel determinant of endothelial function.
Circulation 2007;115(17):2282-91.
2007: Fangwen Rao; Jennifer Wessel; Gen Wen; Lian Zhang; Brinda K Rana; Brian P Kennedy; Tiffany A Greenwood; Rany M Salem; Yuqing Chen; Srikrishna Khandrika; Bruce A Hamilton; Douglas W Smith; Niels-Henrik Holstein-Rathlou; Michael G Ziegler; Nicholas J Schork; Daniel O'Connor
Renal albumin excretion: twin studies identify influences of heredity, environment, and adrenergic pathway polymorphism.
Hypertension 2007;49(5):1015-31.
2007: Carmelle V Remillard; Donna D Tigno; Oleksandr Platoshyn; Elyssa D Burg; Elena E Brevnova; Diane Conger; Ann Nicholson; Brinda K Rana; Richard N Channick; Lewis J Rubin; Daniel O'Connor; Jason X-J Yuan
Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension.
American journal of physiology. Cell physiology 2007;292(5):C1837-53.
2007: Chie Inomoto; Shinobu Umemura; Noboru Egashira; Takeo Minematsu; Susumu Takekoshi; Yoshiko Itoh; Johbu Itoh; LAURENT TAUPENOT; Daniel O'Connor; R Yoshiyuki Osamura
Granulogenesis in non-neuroendocrine COS-7 cells induced by EGFP-tagged chromogranin A gene transfection: identical and distinct distribution of CgA and EGFP.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2007;55(5):487-93.
2007: Jennifer Wessel; Guillermo Moratorio; Fangwen Rao; Manjula Mahata; Lian Zhang; William Greene; Brinda K Rana; Brian P Kennedy; Srikrishna Khandrika; Pauline Huang; Elizabeth O Lillie; Pei-An Betty Shih; Douglas W Smith; Gen Wen; Bruce A Hamilton; Michael G Ziegler; Joseph L Witztum; Nicholas J Schork; Geert W Schmid-Schönbein; Daniel O'Connor
C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci.
Journal of hypertension 2007;25(2):329-43.
2007: Daniel O'Connor; Sushil K Mahata; Manjula Mahata; Qijiao Jiang; Vivian Y H Hook; LAURENT TAUPENOT
Primary culture of bovine chromaffin cells.
Nature protocols 2007;2(5):1248-53.
2007: Brinda K Rana; Paul Insel; Samuel H Payne; Kenneth Abel; Ernest Beutler; Michael G Ziegler; Nicholas J Schork; Daniel O'Connor
Population-based sample reveals gene-gender interactions in blood pressure in White Americans.
Hypertension 2007;49(1):96-106.
2006: Maite COUREL; Carrie Rodemer; Susan T Nguyen; Alena Pance; Antony P Jackson; Daniel O'Connor; LAURENT TAUPENOT
Secretory granule biogenesis in sympathoadrenal cells: identification of a granulogenic determinant in the secretory prohormone chromogranin A.
The Journal of biological chemistry 2006;281(49):38038-51.
2006: Kuixing Zhang; Fangwen Rao; Gen Wen; Rany M Salem; Sucheta M Vaingankar; Manjula Mahata; Nitish R Mahapatra; Elizabeth O Lillie; Peter E Cadman; Ryan S Friese; Bruce A Hamilton; Vivian Y H Hook; Sushil K Mahata; LAURENT TAUPENOT; Daniel O'Connor
Catecholamine storage vesicles and the metabolic syndrome: The role of the chromogranin A fragment pancreastatin.
Diabetes, obesity & metabolism 2006;8(6):621-33.
2006: Nitish R Mahapatra; Manjula Mahata; Sajalendu Ghosh; Jiaur R Gayen; Daniel O'Connor; Sushil K Mahata
Molecular basis of neuroendocrine cell type-specific expression of the chromogranin B gene: Crucial role of the transcription factors CREB, AP-2, Egr-1 and Sp1.
Journal of neurochemistry 2006;99(1):119-33.
2006: Anne Valle; Daniel O'Connor; Palmer Taylor; Gu Zhu; Grant W Montgomery; P Eline Slagboom; Nicholas G Martin; John B Whitfield
Butyrylcholinesterase: association with the metabolic syndrome and identification of 2 gene loci affecting activity.
Clinical chemistry 2006;52(6):1014-20.
2006: Tiffany A Greenwood; Fangwen Rao; Mats Stridsberg; Nitish R Mahapatra; Manjula Mahata; Elizabeth O Lillie; Sushil K Mahata; LAURENT TAUPENOT; Nicholas J Schork; Daniel O'Connor
Pleiotropic effects of novel trans-acting loci influencing human sympathochromaffin secretion.
Physiological genomics 2006;25(3):470-9.
2006: Nitish R Mahapatra; Manjula Mahata; Sushil K Mahata; Daniel O'Connor
The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
Journal of hypertension 2006;24(5):895-904.
2006: Tammy M Seasholtz; Jennifer Wessel; Fangwen Rao; Brinda K Rana; Srikrishna Khandrika; Brian P Kennedy; Elizabeth O Lillie; Michael G Ziegler; Douglas W Smith; Nicholas J Schork; Joan Heller Brown; Daniel O'Connor
Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity.
Hypertension 2006;47(5):937-47.
2006: Elizabeth O Lillie; Daniel O'Connor
Early phenotypic changes in hypertension: a role for the autonomic nervous system and heredity.
Hypertension 2006;47(3):331-3.
2006: Evan Riddle; Brinda K Rana; Kenton K Murthy; Fangwen Rao; Eleazar Eskin; Daniel O'Connor; Paul Insel
Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives.
Hypertension 2006;47(3):415-20.
2005: Brian P Kennedy; Fangwen Rao; T Botiglieri; S Sharma; Elizabeth O Lillie; Michael G Ziegler; Daniel O'Connor
Contributions of the sympathetic nervous system, glutathione, body mass and gender to blood pressure increase with normal aging: influence of heredity.
Journal of human hypertension 2005;19(12):951-69.
2005: Hans-Peter Nothacker; Zhiwei Wang; Hua Zeng; Sushil K Mahata; Daniel O'Connor; Olivier Civelli
Proadrenomedullin N-terminal peptide and cortistatin activation of MrgX2 receptor is based on a common structural motif.
European journal of pharmacology 2005;519(1-2):191-3.
2005: Daniel O'Connor; Peter E Cadman; Clayton Smiley; Rany M Salem; Fangwen Rao; Joshua Smith; Stephen D Funk; Sushil K Mahata; Manjula Mahata; Gen Wen; LAURENT TAUPENOT; Carmen Gonzalez-Yanes; Kimberly L Harper; Robert R Henry; Victor Sanchez-Margalet
Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation in disease, and naturally occurring functional genetic polymorphism.
The Journal of clinical endocrinology and metabolism 2005;90(9):5414-25.
2005: Xuping Bao; Paul J Mills; Brinda K Rana; Joel E Dimsdale; Nicholas J Schork; Douglas W Smith; Fangwen Rao; Milos Milic; Daniel O'Connor; Michael G Ziegler
Interactive effects of common beta2-adrenoceptor haplotypes and age on susceptibility to hypertension and receptor function.
Hypertension 2005;46(2):301-7.
2005: Kenton K Murthy; Vafa S Mahboubi; Alicia Santiago; Mandy T Barragan; Ralph Knöll; Heinz-Peter Schultheiss; Daniel O'Connor; Nicholas J Schork; Brinda K Rana
Assessment of multiple displacement amplification for polymorphism discovery and haplotype determination at a highly polymorphic locus, MC1R.
Human mutation 2005;26(2):145-52.
2005: Nitish R Mahapatra; Daniel O'Connor; Sucheta M Vaingankar; Amiya P Sinha Hikim; Manjula Mahata; Saugata Ray; Eugenie Staite; Hongjiang Wu; Yusu Gu; Nancy Dalton; Brian P Kennedy; Michael G Ziegler; John Ross; Sushil K Mahata
Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.
The Journal of clinical investigation 2005;115(7):1942-52.
2005: Jason P Etzel; Brinda K Rana; Gen Wen; Robert J Parmer; Nicholas J Schork; Daniel O'Connor; Paul Insel
Genetic variation at the human alpha2B-adrenergic receptor locus: role in blood pressure variation and yohimbine response.
Hypertension 2005;45(6):1207-13.
2005: Danuta King; Jason P Etzel; Shagun Chopra; Joshua Smith; Peter E Cadman; Fangwen Rao; Stephen D Funk; Brinda K Rana; Nicholas J Schork; Paul Insel; Daniel O'Connor
Human response to alpha2-adrenergic agonist stimulation studied in an isolated vascular bed in vivo: Biphasic influence of dose, age, gender, and receptor genotype.
Clinical pharmacology and therapeutics 2005;77(5):388-403.
2005: Ryan S Friese; Payam Mahboubi; Nitish R Mahapatra; Sushil K Mahata; Nicholas J Schork; Geert W Schmid-Schönbein; Daniel O'Connor
Common genetic mechanisms of blood pressure elevation in two independent rodent models of human essential hypertension.
American journal of hypertension 2005;18(5 Pt 1):633-52.
2005: Chih-Min Tang; Andre Hoerning; Rainer Büscher; Daniel O'Connor; Felix Ratjen; Hartmut Grasemann; Paul Insel
Human adenosine 2B receptor: SNP discovery and evaluation of expression in patients with cystic fibrosis.
Pharmacogenetics and genomics 2005;15(5):321-7.
2005: LAURENT TAUPENOT; Kimberly L Harper; Daniel O'Connor
Role of H+-ATPase-mediated acidification in sorting and release of the regulated secretory protein chromogranin A: evidence for a vesiculogenic function.
The Journal of biological chemistry 2005;280(5):3885-97.
2005: Herbert Ho; Amar Pinto; Stephen D Hall; David A Flockhart; Lang Li; Todd C Skaar; Peter Cadman; Daniel O'Connor; Urban Wagner; Naomi S Fineberg; Myron H Weinberger
Association between the CYP3A5 genotype and blood pressure.
Hypertension 2005;45(2):294-8.
2004: Nitish R Mahapatra; Manjula Mahata; Partha P Hazra; Patrick M McDonough; Daniel O'Connor; Sushil K Mahata
A dynamic pool of calcium in catecholamine storage vesicles. Exploration in living cells by a novel vesicle-targeted chromogranin A-aequorin chimeric photoprotein.
The Journal of biological chemistry 2004;279(49):51107-21.
2004: Lian Zhang; Fangwen Rao; Jennifer Wessel; Brian P Kennedy; Brinda K Rana; LAURENT TAUPENOT; Elizabeth O Lillie; Myles Cockburn; Nicholas J Schork; Michael G Ziegler; Daniel O'Connor
Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins.
Physiological genomics 2004;19(3):277-91.
2004: Sushil K Mahata; Manjula Mahata; Gen Wen; William B Wong; Nitish R Mahapatra; Bruce A Hamilton; Daniel O'Connor
The catecholamine release-inhibitory "catestatin" fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses.
Molecular pharmacology 2004;66(5):1180-91.
2004: Pascal Le Corre; Robert J Parmer; Mala T Kailasam; Brian P Kennedy; Todd P Skaar; Herbert Ho; Roger Leverge; Douglas W Smith; Michael G Ziegler; Paul Insel; Nicholas J Schork; David A Flockhart; Daniel O'Connor
Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism.
Clinical pharmacology and therapeutics 2004;76(2):139-53.
2004: Tiffany A Greenwood; Peter E Cadman; Mats Stridsberg; Susan Nguyen; LAURENT TAUPENOT; Nicholas J Schork; Daniel O'Connor
Genome-wide linkage analysis of chromogranin B expression in the CEPH pedigrees: implications for exocytotic sympathochromaffin secretion in humans.
Physiological genomics 2004;18(1):119-27.
2004: Ryan S Fries; Payam Mahboubi; Nitish R Mahapatra; Sushil K Mahata; Nicholas J Schork; Geert W Schmid-Schoenbein; Daniel O'Connor
Neuroendocrine transcriptome in genetic hypertension: multiple changes in diverse adrenal physiological systems.
Hypertension 2004;43(6):1301-11.
2004: Nicholas E Preece; Minh Nguyen; Manjula Mahata; Sushil K Mahata; Nitish R Mahapatra; Igor Tsigelny; Daniel O'Connor
Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A.
Regulatory peptides 2004;118(1-2):75-87.
2004: Daniel O'Connor; Moon G Choi; Soon Y Kwon; K-L Paul Sung
New insight into the mechanism of hip prosthesis loosening: effect of titanium debris size on osteoblast function.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2004;22(2):229-36.
2004: Gen Wen; Sushil K Mahata; Peter E Cadman; Manjula Mahata; Sajalendu Ghosh; Nitish R Mahapatra; Fangwen Rao; Mats Stridsberg; Douglas W Smith; Payam Mahboubi; Nicholas J Schork; Daniel O'Connor; Bruce A Hamilton
Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology.
American journal of human genetics 2004;74(2):197-207.
2003: G M Schneider; D W Jacobs; R N Gevirtz; Daniel O'Connor
Cardiovascular haemodynamic response to repeated mental stress in normotensive subjects at genetic risk of hypertension: evidence of enhanced reactivity, blunted adaptation, and delayed recovery.
Journal of human hypertension 2003;17(12):829-40.
2003: Sushil K Mahata; Nitish R Mahapatra; Manjula Mahata; Timothy C Wang; Brian P Kennedy; Michael G Ziegler; Daniel O'Connor
Catecholamine secretory vesicle stimulus-transcription coupling in vivo. Demonstration by a novel transgenic promoter/photoprotein reporter and inhibition of secretion and transcription by the chromogranin A fragment catestatin.
The Journal of biological chemistry 2003;278(34):32058-67.
2003: Clifford Wong; Nitish R Mahapatra; Surin Chitbangonsyn; Payam Mahboubi; Manjula Mahata; Sushil K Mahata; Daniel O'Connor
The angiotensin II receptor (Agtr1a): functional regulatory polymorphisms in a locus genetically linked to blood pressure variation in the mouse.
Physiological genomics 2003;14(1):83-93.
2003: Jean C Lee; Carolyn V Taylor; Sara P Gaucher; Thomas Toneff; LAURENT TAUPENOT; Sukkid Yasothornsrikul; Sushil K Mahata; Catherine Sei; Robert J Parmer; John Neveu; William Stratton Lane; Bradford W Gibson; Daniel O'Connor; Vivian Y H Hook
Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
Biochemistry 2003;42(23):6938-46.
2003: Math P Cuajungco; Yukio Ando; Felicia B Axelrod; Italo Biaggioni; David S Goldstein; Alan E Guttmacher; Katrina Gwinn-Hardy; Maureen K Hahn; Max J Hilz; Giris Jacob; Jordan Jens; William R Kennedy; Stephen B Liggett; Daniel O'Connor; Sonia R Peltzer; David Robertson; Berish Y Rubin; Quandra Scudder; Linda J Smith; Gail E Sonenshein; Jesper Q Svejstrup; Yang Xu; Susan A Slaugenhaupt
Hereditary dysautonomias: current knowledge and collaborations for the future.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2003;13(3):180-95.
2003: Nitish R Mahapatra; Manjula Mahata; Daniel O'Connor; Sushil K Mahata
Secretin activation of chromogranin A gene transcription. Identification of the signaling pathways in cis and in trans.
The Journal of biological chemistry 2003;278(22):19986-94.
2003: S W Chitbangonsyn; Payam Mahboubi; D Walker; Brinda K Rana; K L Diggle; D S Timberlake; Robert J Parmer; Daniel O'Connor
Physical mapping of autonomic/sympathetic candidate genetic loci for hypertension in the human genome: a somatic cell radiation hybrid library approach.
Journal of human hypertension 2003;17(5):319-24.
2003: Caroline M Wong; Daniel O'Connor; Joseph A Martinez; Mala T Kailasam; Robert J Parmer
Diminished renal kallikrein responses to mineralocorticoid stimulation in African Americans: determinants of an intermediate phenotype for hypertension.
American journal of hypertension 2003;16(4):281-9.
2003: LAURENT TAUPENOT; Kimberly L Harper; Daniel O'Connor
The chromogranin-secretogranin family.
The New England journal of medicine 2003;348(12):1134-49.
2003: Noha H Farag; Manjula Mahata; Michael G Ziegler; Daniel O'Connor; Paul J Mills
Hormone replacement therapy increases renal kallikrein excretion in healthy postmenopausal women.
Life sciences 2003;72(11):1279-88.
2003: Peter E Cadman; Daniel O'Connor
Pharmacogenomics of hypertension.
Current opinion in nephrology and hypertension 2003;12(1):61-70.
2002: LAURENT TAUPENOT; Kimberly L Harper; Nitish R Mahapatra; Robert J Parmer; Sushil K Mahata; Daniel O'Connor
Identification of a novel sorting determinant for the regulated pathway in the secretory protein chromogranin A.
Journal of cell science 2002;115(Pt 24):4827-41.
2002: Daniel O'Connor; Mala T Kailasam; Brian P Kennedy; Michael G Ziegler; Noboru Yanaihara; Robert J Parmer
The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension.
Annals of the New York Academy of Sciences 2002;971():533-5.
2002: Fangwen Rao; Harry R Keiser; Daniel O'Connor
Malignant and benign pheochromocytoma: chromaffin granule transmitters and the response to medical and surgical treatment.
Annals of the New York Academy of Sciences 2002;971():530-2.
2002: Peter E Cadman; Fangwen Rao; Sushil K Mahata; Daniel O'Connor
Studies of the dysglycemic peptide, pancreastatin, using a human forearm model.
Annals of the New York Academy of Sciences 2002;971():528-9.
2002: LAURENT TAUPENOT; Kimberly L Harper; Nitish R Mahapatra; Robert J Parmer; Daniel O'Connor
Intracellular protein trafficking into catecholamine storage vesicles: novel chimeric photoproteins visualized by deconvolution fluorescence microscopy.
Annals of the New York Academy of Sciences 2002;971():262-5.
2002: Sushil K Mahata; Nitish R Mahapatra; Manjula Mahata; Daniel O'Connor
Neuroendocrine cell type-specific and inducible expression of chromogranin/secretogranin genes: crucial promoter motifs.
Annals of the New York Academy of Sciences 2002;971():27-38.
2002: Daniel O'Connor; Mala T Kailasam; Brian P Kennedy; Michael G Ziegler; Noboru Yanaihara; Robert J Parmer
Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension.
Journal of hypertension 2002;20(7):1335-45.
2002: Manjula Mahata; Nitish R Mahapatra; Daniel O'Connor; Sushil K Mahata
Chromaffin cell catecholamine secretion: bisindolylmaleimide compounds exhibit novel and potent antagonist effects at the nicotinic cholinergic receptor in pheochromocytoma cells.
Molecular pharmacology 2002;61(6):1340-7.
2002: Carlos J Herrero; Eva Alés; Antonio J Pintado; Manuela G López; Esther García-Palomero; Sushil K Mahata; Daniel O'Connor; Antonio G García; Carmen Montiel
Modulatory mechanism of the endogenous peptide catestatin on neuronal nicotinic acetylcholine receptors and exocytosis.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(2):377-88.
2001: Qijiao Jiang; LAURENT TAUPENOT; Sushil K Mahata; Manjula Mahata; Daniel O'Connor; Lindsey A Miles; Robert J Parmer
Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release.
The Journal of biological chemistry 2001;276(27):25022-9.
2001: Michael Höcker; Thorsten Cramer; Daniel O'Connor; Stefan Rosewicz; Bertram Wiedenmann; Timothy C Wang
Neuroendocrine-specific and gastrin-dependent expression of a chromogranin A-luciferase fusion gene in transgenic mice.
Gastroenterology 2001;121(1):43-55.
2001: Daniel O'Connor; E A Tyrell; Mala T Kailasam; L M Miller; Joseph A Martinez; R R Henry; Robert J Parmer; F B Gabbai
Early alteration in glomerular reserve in humans at genetic risk of essential hypertension: mechanisms and consequences.
Hypertension 2001;37(3):898-906.
2001: D S Timberlake; Daniel O'Connor; Robert J Parmer
Molecular genetics of essential hypertension: recent results and emerging strategies.
Current opinion in nephrology and hypertension 2001;10(1):71-9.
2000: Fangwen Rao; H R Keiser; Daniel O'Connor
Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment.
Hypertension 2000;36(6):1045-52.
2000: LAURENT TAUPENOT; Sushil K Mahata; Manjula Mahata; Robert J Parmer; Daniel O'Connor
Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism.
Regulatory peptides 2000;95(1-3):9-17.
2000: F Lacy; Mala T Kailasam; Daniel O'Connor; Geert W Schmid-Schönbein; Robert J Parmer
Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity.
Hypertension 2000;36(5):878-84.
2000: Mala T Kailasam; Robert J Parmer; E A Tyrell; R R Henry; Daniel O'Connor
Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk.
Journal of hypertension 2000;18(11):1611-20.
2000: Sushil K Mahata; Manjula Mahata; Arun R. Wakade; Daniel O'Connor
Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity.
Molecular endocrinology (Baltimore, Md.) 2000;14(10):1525-35.
2000: Robert J Parmer; Manjula Mahata; Y Gong; Sushil K Mahata; Qijiao Jiang; Daniel O'Connor; XP Xi; Lindsey A Miles
Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion.
The Journal of clinical investigation 2000;106(7):907-15.
2000: Nitish R Mahapatra; Manjula Mahata; A K Datta; Hans-Hermann Gerdes; Wieland B Huttner; Daniel O'Connor; Sushil K Mahata
Neuroendocrine cell type-specific and inducible expression of the chromogranin B gene: crucial role of the proximal promoter.
Endocrinology 2000;141(10):3668-78.
2000: V Herrmann; Rainer Büscher; M M Go; K M Ring; J K Hofer; Mala T Kailasam; Daniel O'Connor; Robert J Parmer; Paul Insel
Beta2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans.
American journal of hypertension 2000;13(9):1021-6.
2000: C V Taylor; LAURENT TAUPENOT; Sushil K Mahata; Manjula Mahata; H Wu; Sukkid Yasothornsrikul; Thomas Toneff; C Caporale; Q Jiang; Robert J Parmer; Vivian Y H Hook; Daniel O'Connor
Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules.
The Journal of biological chemistry 2000;275(30):22905-15.
2000: C K Song; Joseph A Martinez; Mala T Kailasam; T T Dao; C M Wong; Robert J Parmer; Daniel O'Connor
Renal kallikrein excretion: role of ethnicity, gender, environment, and genetic risk of hypertension.
Journal of human hypertension 2000;14(7):461-8.
2000: Daniel O'Connor; P A Insel; Michael G Ziegler; Vivian Y H Hook; Douglas W Smith; Bruce A Hamilton; P W Taylor; Robert J Parmer
Heredity and the autonomic nervous system in human hypertension.
Current hypertension reports 2000;2(1):16-22.
2000: LAURENT TAUPENOT; Manjula Mahata; Sushil K Mahata; H Wu; Daniel O'Connor
Regulation of chromogranin A transcription and catecholamine secretion by the neuropeptide PACAP. Stimulation and desensitization.
Advances in experimental medicine and biology 2000;482():97-111.
2000: Daniel O'Connor; Sushil K Mahata; LAURENT TAUPENOT; Manjula Mahata; C V Livsey Taylor; Mala T Kailasam; Michael G Ziegler; Robert J Parmer
Chromogranin A in human disease.
Advances in experimental medicine and biology 2000;482():377-88.
2000: Sushil K Mahata; Manjula Mahata; C V Livsey Taylor; LAURENT TAUPENOT; Robert J Parmer; Daniel O'Connor
The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364). Properties and function.
Advances in experimental medicine and biology 2000;482():263-77.
2000: Robert J Parmer; Sushil K Mahata; Q Jiang; LAURENT TAUPENOT; Y Gong; Manjula Mahata; Daniel O'Connor; Lindsey A Miles
Tissue plasminogen activator and chromaffin cell function.
Advances in experimental medicine and biology 2000;482():179-92.
1999: LAURENT TAUPENOT; Manjula Mahata; Sushil K Mahata; Daniel O'Connor
Time-dependent effects of the neuropeptide PACAP on catecholamine secretion : stimulation and desensitization.
Hypertension 1999;34(5):1152-62.
1999: Rainer Büscher; V Herrmann; K M Ring; Mala T Kailasam; Daniel O'Connor; R J Parmer; Paul Insel
Variability in phenylephrine response and essential hypertension: a search for human alpha(1B)-adrenergic receptor polymorphisms.
The Journal of pharmacology and experimental therapeutics 1999;291(2):793-8.
1999: Fred A Wright; Daniel O'Connor; E Roberts; G Kutey; C C Berry; L U Yoneda; D Timberlake; G Schlager
Genome scan for blood pressure loci in mice.
Hypertension 1999;34(4 Pt 1):625-30.
1999: Sushil K Mahata; Manjula Mahata; C V Livsey; Hans-Hermann Gerdes; Wieland B Huttner; Daniel O'Connor
Neuroendocrine cell type-specific and inducible expression of the secretogranin II gene: crucial role of cyclic adenosine monophosphate and serum response elements.
Endocrinology 1999;140(2):739-49.
1999: Sushil K Mahata; Manjula Mahata; Robert J Parmer; Daniel O'Connor
Desensitization of catecholamine release. The novel catecholamine release-inhibitory peptide catestatin (chromogranin a344-364) acts at the receptor to prevent nicotinic cholinergic tolerance.
The Journal of biological chemistry 1999;274(5):2920-8.
1999: Daniel O'Connor; M A Takiyyuddin; M P Printz; T Q Dinh; J A Barbosa; David J Rozansky; Sushil K Mahata; H Wu; B P Kennedy; M G Ziegler; Fred A Wright; G Schlager; Robert J Parmer
Catecholamine storage vesicle protein expression in genetic hypertension.
Blood pressure 1999;8(5-6):285-95.
1999: Sushil K Mahata; Manjula Mahata; H Wu; Robert J Parmer; Daniel O'Connor
Neurotrophin activation of catecholamine storage vesicle protein gene expression: signaling to chromogranin a biosynthesis.
Neuroscience 1999;88(2):405-24.
1998: Michael Höcker; Raktima Raychowdhury; Thomas Plath; H Wu; Daniel O'Connor; Bertram Wiedenmann; Stefan Rosewicz; Timothy C Wang
Sp1 and CREB mediate gastrin-dependent regulation of chromogranin A promoter activity in gastric carcinoma cells.
The Journal of biological chemistry 1998;273(51):34000-7.
1998: Mala T Kailasam; Joseph A Martinez; J H Cervenka; Samuel S C Yen; Daniel O'Connor; Robert J Parmer
Racial differences in renal kallikrein excretion: effect of the ovulatory cycle.
Kidney international 1998;54(5):1652-8.
1998: Manjula Mahata; Sushil K Mahata; Robert J Parmer; Daniel O'Connor
Proadrenomedullin N-terminal 20 peptide: minimal active region to regulate nicotinic receptors.
Hypertension 1998;32(5):907-16.
1998: Igor Tsigelny; Sushil K Mahata; LAURENT TAUPENOT; N E Preece; Manjula Mahata; I Khan; Robert J Parmer; Daniel O'Connor
Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activity.
Regulatory peptides 1998;77(1-3):43-53.
1998: C Kong; BM Gill; R Rahimpour; Luoling Xu; Ross D Feldman; Q Xiao; T J McDonald; LAURENT TAUPENOT; Sushil K Mahata; Bhagirath Singh; Daniel O'Connor; David J Kelvin
Secretoneurin and chemoattractant receptor interactions.
Journal of neuroimmunology 1998;88(1-2):91-8.
1998: K Tang; H Wu; Sushil K Mahata; Daniel O'Connor
A crucial role for the mitogen-activated protein kinase pathway in nicotinic cholinergic signaling to secretory protein transcription in pheochromocytoma cells.
Molecular pharmacology 1998;54(1):59-69.
1998: T T Dao; Mala T Kailasam; Robert J Parmer; H V Le; R Le Verge; Brian P Kennedy; G Ziegler; Paul Insel; Fred A Wright; Daniel O'Connor
Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension.
Journal of hypertension 1998;16(6):779-92.
1998: JF Cubells; Daniel P van Kammen; M E Kelley; G M Anderson; Daniel O'Connor; Lawrence H Price; Robert T Malison; P A Rao; K Kobayashi; T Nagatsu; Joel Gelernter
Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation.
Human genetics 1998;102(5):533-40.
1998: F Lacy; Daniel O'Connor; Geert W Schmid-Schönbein
Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension.
Journal of hypertension 1998;16(3):291-303.
1998: LAURENT TAUPENOT; Sushil K Mahata; H Wu; Daniel O'Connor
Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).
The Journal of clinical investigation 1998;101(4):863-76.
1998: Brian P Kennedy; Sushil K Mahata; Daniel O'Connor; Michael G Ziegler
Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo.
Peptides 1998;19(7):1241-8.
1998: Sushil K Mahata; Manjula Mahata; S H Yoo; LAURENT TAUPENOT; H Wu; V R Aroda; C V Livsey; Joseph P Taulane; Murray Goodman; Robert J Parmer; Daniel O'Connor
A novel, catecholamine release-inhibitory peptide from chromogranin A: autocrine control of nicotinic cholinergic-stimulated exocytosis.
Advances in pharmacology (San Diego, Calif.) 1998;42():260-4.
1997: Sushil K Mahata; Daniel O'Connor; Manjula Mahata; S H Yoo; LAURENT TAUPENOT; H Wu; BM Gill; Robert J Parmer
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
The Journal of clinical investigation 1997;100(6):1623-33.
1997: K Tang; H Wu; Sushil K Mahata; Manjula Mahata; BM Gill; Robert J Parmer; Daniel O'Connor
Stimulus coupling to transcription versus secretion in pheochromocytoma cells. Convergent and divergent signal transduction pathways and the crucial roles for route of cytosolic calcium entry and protein kinase C.
The Journal of clinical investigation 1997;100(5):1180-92.
1997: T J Brinton; B Cotter; Mala T Kailasam; D L Brown; S S Chio; Daniel O'Connor; A N DeMaria
Development and validation of a noninvasive method to determine arterial pressure and vascular compliance.
The American journal of cardiology 1997;80(3):323-30.
1997: Robert J Parmer; Manjula Mahata; Sushil K Mahata; M T Sebald; Daniel O'Connor; Lindsey A Miles
Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA.
The Journal of biological chemistry 1997;272(3):1976-82.
1996: K Tang; H Wu; Sushil K Mahata; LAURENT TAUPENOT; David J Rozansky; Robert J Parmer; Daniel O'Connor
Stimulus-transcription coupling in pheochromocytoma cells. Promoter region-specific activation of chromogranin a biosynthesis.
The Journal of biological chemistry 1996;271(45):28382-90.
1996: T J Brinton; Mala T Kailasam; R A Wu; J H Cervenka; S S Chio; Robert J Parmer; A N DeMaria; Daniel O'Connor
Arterial compliance by cuff sphygmomanometer. Application to hypertension and early changes in subjects at genetic risk.
Hypertension 1996;28(4):599-603.
1996: Manjula Mahata; Sushil K Mahata; Robert J Parmer; Daniel O'Connor
Vesicular monoamine transport inhibitors. Novel action at calcium channels to prevent catecholamine secretion.
Hypertension 1996;28(3):414-20.
1996: N L Eskeland; A Zhou; T Q Dinh; H Wu; Robert J Parmer; R E Mains; Daniel O'Connor
Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway.
The Journal of clinical investigation 1996;98(1):148-56.
1996: Mala T Kailasam; Daniel O'Connor; Robert J Parmer
Hereditary intermediate phenotypes in African American hypertension.
Ethnicity & health 1996;1(2):117-28.
1996: Daniel O'Connor; Mala T Kailasam; Robert J Parmer
Complex trait genetics: new methods yield a result for essential hypertension.
The Journal of clinical investigation 1996;97(9):1997-8.
1996: Sushil K Mahata; C A Kozak; J Szpirer; Claude Szpirer; W S Modi; H H Gerdes; W B Huttner; Daniel O'Connor
Dispersion of chromogranin/secretogranin secretory protein family loci in mammalian genomes.
Genomics 1996;33(1):135-9.
1995: Luigi X Cubeddu; Daniel O'Connor; I Hoffmann; R J Parmer
Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies.
British journal of cancer 1995;72(4):1033-8.
1995: H Wu; Sushil K Mahata; Manjula Mahata; Nicholas J G Webster; Robert J Parmer; Daniel O'Connor
A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A.
The Journal of clinical investigation 1995;96(1):568-78.
1995: Mala T Kailasam; Robert J Parmer; J H Cervenka; R A Wu; Michael G Ziegler; B P Kennedy; I A Adegbile; Daniel O'Connor
Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension.
Hypertension 1995;26(1):143-9.
1995: Mala T Kailasam; Robert J Parmer; R A Stone; S Shankel; B P Kennedy; Michael G Ziegler; Daniel O'Connor
Factitious pheochromocytoma: novel mimickry by Valsalva maneuver and clues to diagnosis.
American journal of hypertension 1995;8(6):651-5.
1995: J A Martinez; Daniel O'Connor
Somatic cell gene therapy for a trait as complex as hypertension?
The Journal of clinical investigation 1995;95(4):1426.
1995: Luigi X Cubeddu; Daniel O'Connor; R J Parmer
Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):681-7.
1994: David J Rozansky; H Wu; K Tang; Robert J Parmer; Daniel O'Connor
Glucocorticoid activation of chromogranin A gene expression. Identification and characterization of a novel glucocorticoid response element.
The Journal of clinical investigation 1994;94(6):2357-68.
1994: R A Wu; Mala T Kailasam; J H Cervenka; Robert J Parmer; B P Kennedy; Michael G Ziegler; Daniel O'Connor
Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?
Journal of hypertension 1994;12(11):1243-7.
1994: Daniel O'Connor; H Wu; BM Gill; David J Rozansky; K Tang; Sushil K Mahata; Manjula Mahata; N L Eskeland; J S Videen; X Zhang
Hormone storage vesicle proteins. Transcriptional basis of the widespread neuroendocrine expression of chromogranin A, and evidence of its diverse biological actions, intracellular and extracellular.
Annals of the New York Academy of Sciences 1994;733():36-45.
1994: H Wu; David J Rozansky; Nicholas J G Webster; Daniel O'Connor
Cell type-specific gene expression in the neuroendocrine system. A neuroendocrine-specific regulatory element in the promoter of chromogranin A, a ubiquitous secretory granule core protein.
The Journal of clinical investigation 1994;94(1):118-29.
1994: Mala T Kailasam; M C Lin; J H Cervenka; Robert J Parmer; B P Kennedy; Michael G Ziegler; Daniel O'Connor
Effects of an oral prostaglandin E1 agonist on blood pressure and its determinants in essential hypertension.
Journal of human hypertension 1994;8(7):515-20.
1994: M A Takiyyuddin; M R Brown; T Q Dinh; J H Cervenka; S D Braun; Robert J Parmer; B Kennedy; Daniel O'Connor
Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release.
Journal of autonomic pharmacology 1994;14(3):187-200.
1994: Unni Syversen; M B Jacobsen; Daniel O'Connor; K Rønning; Helge L Waldum
Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia.
Neuropeptides 1994;26(3):201-6.
1994: Daniel P van Kammen; ME Kelley; M W Gilbertson; John A Gurklis; Daniel O'Connor
CSF dopamine beta-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures.
The American journal of psychiatry 1994;151(3):372-8.
1994: Daniel P van Kammen; Hans Agren; Jeffrey K Yao; Daniel O'Connor; John A Gurklis; J L Peters
Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia.
The American journal of psychiatry 1994;151(3):379-84.
1994: Daniel O'Connor; J H Cervenka; R A Stone; G L Levine; Robert J Parmer; Rebecca E Franco-Bourland; Ignacio Madrazo; P J Langlais; D Robertson; I Biaggioni
Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency.
Clinical science (London, England : 1979) 1994;86(2):149-58.
1994: G E Garcia; Francis B Gabbai; Daniel O'Connor; T Q Dinh; B Kennedy; Michael G Ziegler; M A Takiyyuddin
Does chromostatin influence catecholamine release or blood pressure in vivo?
Peptides 1994;15(1):195-7.
1993: Daniel O'Connor; J H Cervenka; R A Stone; Robert J Parmer; Rebecca E Franco-Bourland; Ignacio Madrazo; P J Langlais
Chromogranin A immunoreactivity in human cerebrospinal fluid: properties, relationship to noradrenergic neuronal activity, and variation in neurologic disease.
Neuroscience 1993;56(4):999-1007.
1993: D Simon-Chazottes; H Wu; Robert J Parmer; David J Rozansky; J Szpirer; G Levan; theodore kurtz; Claude Szpirer; J L Guenet; Daniel O'Connor
Assignment of the chromogranin A (Chga) locus to homologous regions on mouse chromosome 12 and rat chromosome 6.
Genomics 1993;17(1):252-5.
1993: M A Takiyyuddin; L De Nicola; Francis B Gabbai; T Q Dinh; B Kennedy; Michael G Ziegler; E L Sabban; Robert J Parmer; Daniel O'Connor
Catecholamine secretory vesicles. Augmented chromogranins and amines in secondary hypertension.
Hypertension 1993;21(5):674-9.
1993: Daniel O'Connor; Mala T Kailasam; Leon J Thal
Cerebrospinal fluid chromogranin A is unchanged in Alzheimer dementia.
Neurobiology of aging 1993;14(3):267-9.
1993: Robert J Parmer; Lindsey A Miles; XP Xi; BM Gill; H J Wu; Daniel O'Connor
Processing of chromaffin granule proteins: a profusion of proteases?
Neurochemistry international 1993;22(4):361-7.
1992: P A Sullivan; C Grosch; D Lawless; Daniel O'Connor
Short-term strenuous exercise training: effects on blood pressure and hormonal levels in mild hypertension.
Irish journal of medical science 1992;161(12):666-9.
1992: H Bender; A Maier; B Wiedenmann; Daniel O'Connor; K Messner; H Schmidt-Gayk
Immunoluminometric assay of chromogranin A in serum with commercially available reagents.
Clinical chemistry 1992;38(11):2267-72.
1992: Unni Syversen; Helge L Waldum; Daniel O'Connor
Rapid, high-yield isolation of human chromogranin A from chromaffin granules of pheochromocytomas.
Neuropeptides 1992;22(4):235-40.
1992: Daniel P van Kammen; Daniel O'Connor; Thomas Neylan; A Mouton; John A Gurklis; M W Gilbertson; J L Peters
CSF chromogranin A-like immunoreactivity in schizophrenia: relationships with REM latency and slow wave sleep.
Psychiatry research 1992;42(1):53-63.
1992: J S Videen; M S Mezger; Y M Chang; Daniel O'Connor
Calcium and catecholamine interactions with adrenal chromogranins. Comparison of driving forces in binding and aggregation.
The Journal of biological chemistry 1992;267(5):3066-73.
1992: BM Gill; J A Barbosa; Ruth Hogue Angeletti; N Varki; Daniel O'Connor
Chromogranin A epitopes: clues from synthetic peptides and peptide mapping.
Neuropeptides 1992;21(2):105-18.
1992: Joel E Dimsdale; Daniel O'Connor; M Ziegler; P Mills
Chromogranin A correlates with norepinephrine release rate.
Life sciences 1992;51(7):519-25.
1992: E Blind; Heinrich Schmidt-Gayk; H P Sinn; Daniel O'Connor; Friedhelm Raue
Chromogranin A as tumor marker in medullary thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association 1992;2(1):5-10.
1991: Daniel O'Connor; R L Klein; A K Thureson-Klein; J A Barbosa
Chromogranin A: localization and stoichiometry in large dense core catecholamine storage vesicles from sympathetic nerve.
Brain research 1991;567(2):188-96.
1991: P J Rogers; G M Tyce; R M Weinshilboum; Daniel O'Connor; kent bailey; A A Bove
Catecholamine metabolic pathways and exercise training. Plasma and urine catecholamines, metabolic enzymes, and chromogranin-A.
Circulation 1991;84(6):2346-56.
1991: D P van Kammen; J Peters; J Yao; Thomas Neylan; M Beuger; E Pontius; Daniel O'Connor
CSF chromogranin A-like immunoreactivity in schizophrenia. Assessment of clinical and biochemical relationships.
Schizophrenia research 1991;6(1):31-9.
1991: M A Takiyyuddin; H P Neumann; J H Cervenka; B Kennedy; T Q Dinh; Michael G Ziegler; Alain D Baron; Daniel O'Connor
Ultradian variations of chromogranin A in humans.
The American journal of physiology 1991;261(4 Pt 2):R939-44.
1991: Matthew Ito; Daniel O'Connor
Skin pretreatment and the use of transdermal clonidine.
The American journal of medicine 1991;91(1A):42S-49S.
1991: H J Wu; David J Rozansky; Robert J Parmer; BM Gill; Daniel O'Connor
Structure and function of the chromogranin A gene. Clues to evolution and tissue-specific expression.
The Journal of biological chemistry 1991;266(20):13130-4.
1991: Daniel O'Connor
The wise for cure on exercise depend.
Circulation 1991;83(5):1822-3.
1991: BM Gill; J A Barbosa; T Q Dinh; S Garrod; Daniel O'Connor
Chromogranin B: isolation from pheochromocytoma, N-terminal sequence, tissue distribution and secretory vesicle processing.
Regulatory peptides 1991;33(2):223-35.
1991: S J McGrath-Linden; C F Johnston; Daniel O'Connor; C Shaw; Keith D Buchanan
Pancreastatin-like immunoreactivity in human carcinoid disease.
Regulatory peptides 1991;33(1):55-70.
1991: Clifford W Shults; Daniel O'Connor; Andrew Baird; R Hill; Christopher G Goetz; Ray L Watts; H L Klawans; Paul Carvey; Roy A E Bakay; F H Gage
Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid.
Experimental neurology 1991;111(3):276-81.
1991: Gary S Wand; M Takiyyuddin; Daniel O'Connor; Michael Levine
A proposed role for chromogranin A as a glucocorticoid-responsive autocrine inhibitor of proopiomelanocortin secretion.
Endocrinology 1991;128(3):1345-51.
1991: M A Takiyyuddin; Alain D Baron; J H Cervenka; J A Barbosa; H P Neumann; Robert J Parmer; P A Sullivan; Daniel O'Connor
Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies.
The Journal of clinical endocrinology and metabolism 1991;72(3):616-22.
1991: R J Hsiao; Robert J Parmer; M A Takiyyuddin; Daniel O'Connor
Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.
Medicine 1991;70(1):33-45.
1991: J A Barbosa; BM Gill; M A Takiyyuddin; Daniel O'Connor
Chromogranin A: posttranslational modifications in secretory granules.
Endocrinology 1991;128(1):174-90.
1990: J T Mullen; Daniel O'Connor
Potassium effects on blood pressure: is the conjugate anion important?
Journal of human hypertension 1990;4(6):589-96.
1990: M A Takiyyuddin; J H Cervenka; MR Pandian; C A Stuenkel; H P Neumann; Daniel O'Connor
Neuroendocrine sources of chromogranin-A in normal man: clues from selective stimulation of endocrine glands.
The Journal of clinical endocrinology and metabolism 1990;71(2):360-9.
1990: R E Powers; Daniel O'Connor; Donald L Price
Noradrenergic innervation of human inferior olivary complex.
Brain research 1990;523(1):151-5.
1990: H J Wu; Robert J Parmer; A H Koop; David J Rozansky; Daniel O'Connor
Molecular cloning, structure, and expression of dopamine-beta-hydroxylase from bovine adrenal medulla.
Journal of neurochemistry 1990;55(1):97-105.
1990: R J Hsiao; H P Neumann; Robert J Parmer; J A Barbosa; Daniel O'Connor
Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution.
The American journal of medicine 1990;88(6):607-13.
1990: Michael G Ziegler; B Kennedy; E Morrissey; Daniel O'Connor
Norepinephrine clearance, chromogranin A and dopamine beta hydroxylase in renal failure.
Kidney international 1990;37(5):1357-62.
1990: R J Hsiao; Robert C Seeger; Alice L Yu; Daniel O'Connor
Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival.
The Journal of clinical investigation 1990;85(5):1555-9.
1990: B E Stabile; Thomas J Howard; E Passaro; Daniel O'Connor
Source of plasma chromogranin A elevation in gastrinoma patients.
Archives of surgery (Chicago, Ill. : 1960) 1990;125(4):451-3.
1990: Robert J Parmer; J H Cervenka; R A Stone; Daniel O'Connor
Autonomic function in hypertension. Are there racial differences?
Circulation 1990;81(4):1305-11.
1990: M A Takiyyuddin; J H Cervenka; R J Hsiao; J A Barbosa; Robert J Parmer; Daniel O'Connor
Chromogranin A. Storage and release in hypertension.
Hypertension 1990;15(3):237-46.
1990: R J Hsiao; M S Mezger; Daniel O'Connor
Chromogranin A in uremia: progressive retention of immunoreactive fragments.
Kidney international 1990;37(3):955-64.
1990: M A Takiyyuddin; J H Cervenka; P A Sullivan; MR Pandian; Robert J Parmer; J A Barbosa; Daniel O'Connor
Is physiologic sympathoadrenal catecholamine release exocytotic in humans?
Circulation 1990;81(1):185-95.
1990: S W Carmichael; S L Stoddard; Daniel O'Connor; T L Yaksh; GM Tyce
The secretion of catecholamines, chromogranin A and neuropeptide Y from the adrenal medulla of the cat via the adrenolumbar vein and thoracic duct: different anatomic routes based on size.
Neuroscience 1990;34(2):433-40.
1990: R Polikar; B Kennedy; M Ziegler; Daniel O'Connor; J Smith; P Nicod
Plasma norepinephrine kinetics, dopamine-beta-hydroxylase, and chromogranin-A, in hypothyroid patients before and following replacement therapy.
The Journal of clinical endocrinology and metabolism 1990;70(1):277-81.
1990: G Lahr; C Heiss; Artur Mayerhofer; Karl Schilling; R J Parmer; Daniel O'Connor; Manfred Gratzl
Chromogranin A in the olfactory system of the rat.
Neuroscience 1990;39(3):605-11.
1990: Daniel O'Connor; M A Takiyyuddin; J H Cervenka; Robert J Parmer; J A Barbosa; Y M Chang; R J Hsiao
Circulating chromogranin A as a diagnostic tool in clinical chemistry.
Acta histochemica. Supplementband 1990;38():27-33.
1989: M S Nanes; Daniel O'Connor; Stephen J Marx
Plasma chromogranin-A in primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 1989;69(5):950-5.
1989: Robert J Parmer; A H Koop; M T Handa; Daniel O'Connor
Molecular cloning of chromogranin A from rat pheochromocytoma cells.
Hypertension 1989;14(4):435-44.
1989: Daniel O'Connor; M R Pandlan; E Carlton; J H Cervenka; R J Hslao
Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure.
Clinical chemistry 1989;35(8):1631-7.
1989: Leonard J Deftos; Daniel O'Connor; Charles B Wilson; Paul A Fitzgerald
Human pituitary tumors secrete chromogranin-A.
The Journal of clinical endocrinology and metabolism 1989;68(5):869-72.
1989: C A Jengeleski; R E Powers; Daniel O'Connor; Donald L Price
Noradrenergic innervation of human pineal gland: abnormalities in aging and Alzheimer's disease.
Brain research 1989;481(2):378-82.
1989: R W Gifford; W Kirkendall; Daniel O'Connor; W Weidman
Office evaluation of hypertension. A statement for health professionals by a writing group of the Council for High Blood Pressure Research, American Heart Association.
Circulation 1989;79(3):721-31.
1989: P A Sullivan; J Cervenka; Daniel O'Connor; M Dineen
Fosenopril, an angiotensin-converting enzyme inhibitor, and propranolol: comparative effects at rest and exercise on blood pressure, hormonal variables, and plasma potassium in essential hypertension.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1989;3(1):57-62.
1989: R E Powers; Daniel O'Connor; Donald L Price
Noradrenergic systems in human cerebellum.
Brain research 1989;481(1):194-9.
1989: M A Takiyyuddin; J H Cervenka; T Dinh; J L Witztum; Daniel O'Connor
Selective alpha-blockade versus angiotensin-converting enzyme inhibition as initial antihypertensive therapy. Effects on circulating lipoproteins.
The American journal of medicine 1989;86(1B):32-5.
1988: Daniel O'Connor; S Subramani
Do transcriptional enhancers also augment DNA replication?
Nucleic acids research 1988;16(23):11207-22.
1988: M Simonsson; S Eriksson; R Håkanson; T Lind; H Lönroth; L Lundell; Daniel O'Connor; F Sundler
Endocrine cells in the human oxyntic mucosa. A histochemical study.
Scandinavian journal of gastroenterology 1988;23(9):1089-99.
1988: P A Sullivan; M Dineen; J Cervenka; Daniel O'Connor
Effects of fosenopril, a once-daily angiotensin-converting enzyme inhibitor, on resting and exercise-induced changes of blood pressure, hormonal variables, and plasma potassium in essential hypertension.
American journal of hypertension 1988;1(3 Pt 3):280S-283S.
1988: Leonard J Deftos; R I Linnoila; D N Carney; D W Burton; S S Leong; Daniel O'Connor; Samuel S Murray; A F Gazdar
Demonstration of Chromogranin A in human neuroendocrine cell lines by immunohistology and immunoassay.
Cancer 1988;62(1):92-7.
1988: R E Powers; R G Struble; M F Casanova; Daniel O'Connor; C A Kitt; Donald L Price
Innervation of human hippocampus by noradrenergic systems: normal anatomy and structural abnormalities in aging and in Alzheimer's disease.
Neuroscience 1988;25(2):401-17.
1988: R J Parmer; Daniel O'Connor
Enkephalins in human phaeochromocytomas: localization in immunoreactive, high molecular weight form to the soluble core of chromaffin granules.
Journal of hypertension 1988;6(3):187-98.
1988: M J Cooper; Lee Helman; A E Evans; S Swamy; Daniel O'Connor; L Helson; Mark Israel
Chromogranin A expression in childhood peripheral neuroectodermal tumors.
Progress in clinical and biological research 1988;271():175-84.
1987: C M Kemper; Daniel O'Connor; Karin N Westlund
Immunocytochemical localization of dopamine-beta-hydroxylase in neurons of the human brain stem.
Neuroscience 1987;23(3):981-9.
1987: Daniel O'Connor; L Strause; P Saltman; R J Parmer; J Cervenka
Serum zinc is unaffected by effective captopril treatment of hypertension.
Journal of clinical hypertension 1987;3(4):405-8.
1987: M Schober; Reiner Fischer-Colbrie; Kurt W Schmid; G Bussolati; Daniel O'Connor; H Winkler
Comparison of chromogranins A, B, and secretogranin II in human adrenal medulla and pheochromocytoma.
Laboratory investigation; a journal of technical methods and pathology 1987;57(4):385-91.
1987: L E Eiden; W B Huttner; J Mallet; Daniel O'Connor; H Winkler; A Zanini
A nomenclature proposal for the chromogranin/secretogranin proteins.
Neuroscience 1987;21(3):1019-21.
1987: L J Deftos; B T Björnsson; D W Burton; Daniel O'Connor; D H Copp
Chromogranin A is present in and released by fish endocrine tissue.
Life sciences 1987;40(22):2133-6.
1987: Daniel O'Connor; L J Deftos
How sensitive and specific is measurement of plasma chromogranin A for the diagnosis of neuroendocrine neoplasia?
Annals of the New York Academy of Sciences 1987;493():379-86.
1987: JM Lauweryns; L van Ranst; R V Lloyd; Daniel O'Connor
Chromogranin in bronchopulmonary neuroendocrine cells. Immunocytochemical detection in human, monkey, and pig respiratory mucosa.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1987;35(1):113-8.
1986: R E Sobol; Daniel O'Connor; J Addison; K Suchocki; I Royston; L J Deftos
Elevated serum chromogranin A concentrations in small-cell lung carcinoma.
Annals of internal medicine 1986;105(5):698-700.
1986: L J Deftos; Samuel S Murray; D W Burton; R J Parmer; Daniel O'Connor; A M Delegeane; P L Mellon
A cloned chromogranin A (CgA) cDNA detects a 2.3Kb mRNA in diverse neuroendocrine tissues.
Biochemical and biophysical research communications 1986;137(1):418-23.
1986: Daniel O'Connor; L J Deftos
Secretion of chromogranin A by peptide-producing endocrine neoplasms.
The New England journal of medicine 1986;314(18):1145-51.
1985: Daniel O'Connor
Plasma chromogranin A. Initial studies in human hypertension.
Hypertension 1985;7(3 Pt 2):I76-9.
1985: W Kruggel; Daniel O'Connor; Randolph V Lewis
The amino terminal sequences of bovine and human chromogranin A and secretory protein I are identical.
Biochemical and biophysical research communications 1985;127(1):380-3.
1985: R L Sokoloff; R P Frigon; Daniel O'Connor
Dopamine-beta-hydroxylase: structural comparisons of membrane-bound versus soluble forms from adrenal medulla and pheochromocytoma.
Journal of neurochemistry 1985;44(2):411-20.
1984: Daniel O'Connor
Chromogranin A: implications for hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1984;2(3):S147-50.
1984: Daniel O'Connor; C A Mosley; J Cervenka; K N Bernstein
Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1984;2(2):S89-92.
1984: G Serck-Hanssen; Daniel O'Connor
Immunological identification and characterization of chromogranins coded by poly(A) mRNA from bovine adrenal medulla and pituitary gland and human phaeochromocytoma.
The Journal of biological chemistry 1984;259(18):11597-600.
1984: Daniel O'Connor; K N Bernstein
Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma.
The New England journal of medicine 1984;311(12):764-70.
1984: Daniel O'Connor; R P Frigon
Chromogranin A, the major catecholamine storage vesicle soluble protein. Multiple size forms, subcellular storage, and regional distribution in chromaffin and nervous tissue elucidated by radioimmunoassay.
The Journal of biological chemistry 1984;259(5):3237-47.
1984: G Sugino; A P Barg; Daniel O'Connor
Renal perfusion is preserved during cardioselective beta-blockade with metoprolol in hypertension.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1984;3(5):357-61.
1984: Daniel O'Connor; R P Frigon; R L Sokoloff
Human chromogranin A. Purification and characterization from catecholamine storage vesicles of human pheochromocytoma.
Hypertension 1984;6(1):2-12.
1984: Daniel O'Connor; R J Parmer; L J Deftos
Chromogranin A: studies in the endocrine system.
Transactions of the Association of American Physicians 1984;97():242-50.
1984: K N Bernstein; Daniel O'Connor
Antiadrenergic antihypertensive drugs: their effect on renal function.
Annual review of pharmacology and toxicology 1984;24():105-20.
1984: C Mosley; Daniel O'Connor; A Taylor; R A Slutsky; J Cervenka
Comparative effects of antihypertensive therapy with guanabenz and propranolol on renal vascular resistance and left ventricular mass.
Journal of cardiovascular pharmacology 1984;6 Suppl 5():S757-61.
1983: Daniel O'Connor; D Burton; L J Deftos
Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues.
The Journal of clinical endocrinology and metabolism 1983;57(5):1084-6.
1983: Daniel O'Connor; D Burton; L J Deftos
Chromogranin A: immunohistology reveals its universal occurrence in normal polypeptide hormone producing endocrine glands.
Life sciences 1983;33(17):1657-63.
1983: Daniel O'Connor; G L Levine; R P Frigon
Homologous radio-immunoassay of human plasma dopamine-beta-hydroxylase: analysis of homospecific activity, circulating plasma pool and intergroup differences based on race, blood pressure and cardiac function.
Journal of hypertension 1983;1(3):227-33.
1983: K N Bernstein; A P Barg; Daniel O'Connor
Nadolol: evidence for sympathetic nerve inhibition by a beta blocker in essential hypertension.
Journal of hypertension 1983;1(3):291-6.
1983: M D Snavely; L C Mahan; Daniel O'Connor; Paul Insel
Selective down-regulation of adrenergic receptor subtypes in tissues from rats with pheochromocytoma.
Endocrinology 1983;113(1):354-61.
1983: Daniel O'Connor
Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum.
Regulatory peptides 1983;6(3):263-80.
1983: S E Warren; Daniel O'Connor; I M Cohen
Autonomic and baroreflex function after captopril in hypertension.
American heart journal 1983;105(6):1002-8.
1983: I Gozes; Daniel O'Connor; F E Bloom
A possible high molecular weight precursor to vasoactive intestinal polypeptide sequestered into pheochromocytoma chromaffin granules.
Regulatory peptides 1983;6(2):111-9.
1983: Daniel O'Connor; R P Frigon; L J Deftos
Immunoreactive calcitonin in catecholamine storage vesicles of human pheochromocytoma.
The Journal of clinical endocrinology and metabolism 1983;56(3):582-5.
1983: H J Motulsky; Daniel O'Connor; P A Insel
Platelet alpha 2-adrenergic receptors in treated and untreated essential hypertension.
Clinical science (London, England : 1979) 1983;64(3):265-72.
1983: A R Olshan; Daniel O'Connor; I M Cohen; J A Mitas; R A Stone
Baroreflex dysfunction in patients with adult-onset diabetes and hypertension.
The American journal of medicine 1983;74(2):233-42.
1983: Daniel O'Connor; N Gochman
Lactic dehydrogenase activity in human pheochromocytoma.
JAMA : the journal of the American Medical Association 1983;249(3):383-5.
1982: Daniel O'Connor; A P Barg; W Amend; F Vincenti
Urinary kallikrein excretion after renal transplantation: relationship to hypertension, graft source, and renal function.
The American journal of medicine 1982;73(4):475-81.
1982: Daniel O'Connor
Response of the renal kallikrein-kinin system, intravascular volume, and renal hemodynamics to sodium restriction and diuretic treatment in essential hypertension.
Hypertension 1982;4(5 Pt 2):III72-8.
1982: A R Olshan; Daniel O'Connor; I M Cohen; R A Stone
Hypertension in adult onset diabetes mellitus: abnormal renal hemodynamics and endogenous vasoregulatory factors.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1982;2(2):271-80.
1982: Daniel O'Connor; Richard A Preston
Urinary kallikrein activity, renal hemodynamics, and electrolyte handling during chronic beta blockade with propranolol in hypertension.
Hypertension 1982;4(5):742-9.
1982: Daniel O'Connor; Richard A Preston
Propranolol effects on autonomic function in hypertensive men.
Clinical cardiology 1982;5(5):340-6.
1982: Daniel O'Connor; A P Barg; K L Duchin
Preserved renal perfusion during treatment of essential hypertension with the beta blocker nadolol.
Journal of clinical pharmacology 1982;22(4):187-95.
1982: E H Sasso; Daniel O'Connor
Prazosin depression of baroreflex function in hypertensive man.
European journal of clinical pharmacology 1982;22(1):7-14.
1981: M A Schuckit; Daniel O'Connor; J Duby; R Vega; M Moss
Dopamine-beta-hydroxylase activity levels in men at high risk for alcoholism and controls.
Biological psychiatry 1981;16(11):1067-75.
1981: S E Warren; Daniel O'Connor
The antihypertensive mechanism of sodium restriction.
Journal of cardiovascular pharmacology 1981;3(4):781-90.
1981: R P Frigon; Daniel O'Connor; G L Levine
Human dopamine-beta-hydroxylase: comparison of the enzyme from plasma, adrenal medulla, and pheochromocytoma by radioimmunoassay.
Molecular pharmacology 1981;19(3):444-50.
1981: S E Warren; Daniel O'Connor; I M Cohen; J A Mitas
Renal hemodynamic changes during long-term antihypertensive therapy.
Clinical pharmacology and therapeutics 1981;29(3):310-7.
1981: I M Cohen; Daniel O'Connor; Richard A Preston; R A Stone
Long-term clonidine effects on autonomic function in essential hypertensive man.
European journal of clinical pharmacology 1981;19(1):25-32.
1981: Daniel O'Connor; Richard A Preston; J A Mitas; R P Frigon; R A Stone
Urinary kallikrein activity and renal vascular resistance in the antihypertensive response to thiazide diuretics.
Hypertension 1981;3(1):139-47.
1981: A R Olshan; Daniel O'Connor; Richard A Preston; R P Frigon; R A Stone
Involvement of kallikrein in the antihypertensive response to furosemide in essential hypertension.
Journal of cardiovascular pharmacology 1981;3(1):161-7.
1980: S E Warren; Daniel O'Connor
Hyperkalemia resulting from captopril administration.
JAMA : the journal of the American Medical Association 1980;244(22):2551-2.